Successful treatment of aggressive AA amyloidosis with tocilizumab in a patient with polymyalgia rheumatica

被引：0
|
作者：
Atas, Nuh [1 ]
Caliskan, Ali Riza [2 ]
Akatli, Aysenur [3 ]
机构：
[1] Adiyaman Educ & Res Hosp, Dept Internal Med, Div Rheumatol, TR-2230 Adiyaman, Turkiye
[2] Adiyaman Educ & Res Hosp, Dept Internal Med, Div Gastroenterol, Adiyaman, Turkiye
[3] Inonu Univ, Fac Med, Dept Pathol, Malatya, Turkiye
来源：
MODERN RHEUMATOLOGY CASE REPORTS | 2024年
关键词：
Polymyalgia rheumatica; AA amyloidosis; tocilizumab; IL-6; proteinuria; SECONDARY;
D O I：
10.1093/mrcr/rxae050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Polymyalgia rheumatic (PMR) associated amyloidosis is an extremely rare condition that can be rapidly progressive with high morbidity and mortality and management is challenging. Tocilizumab is a monoclonal anti-IL-6 receptor antibody, which is in the therapeutic arsenal of PMR. The efficiency of tocilizumab in improvement of PMR activity score and decreasing steroid dose is well-established, while efficiency in PMR-associated amyloidosis has not been published. Herein, we reported a PMR patient with amyloid A amyloidosis who was treated effectively with tocilizumab.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Tocilizumab for polymyalgia rheumatica
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (04): : E250 - E250
  • [2] Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica
    Escribá, A
    Morales, E
    Albizúa, E
    Herrero, JC
    Ortuño, T
    Carreño, A
    Dominguez-Gil, B
    Praga, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) : 137 - 140
  • [3] RAPID DEVELOPMENT OF RENAL FAILURE SECONDARY TO AA-TYPE AMYLOIDOSIS IN A PATIENT WITH POLYMYALGIA RHEUMATICA
    Javaid, Muhammad Masoom
    Kamalanathan, Manivarma
    Sui Phin Kon
    JOURNAL OF RENAL CARE, 2010, 36 (04) : 199 - 202
  • [4] Tocilizumab for treatment of large vessel vasculitis and polymyalgia rheumatica
    Henes, J. C.
    Xenitidis, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (05): : 486 - 487
  • [5] Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
    Filippi, Federica
    Chessa, Marco A.
    Patrizi, Annalisa
    Baraldi, Carlotta
    Ferrara, Francesca
    Bardazzi, Federico
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2020, 10 (01):
  • [6] Successful treatment with clarithromycin for patients with polymyalgia rheumatica
    Ohe, Masashi
    Bohgaki, Toshiyuki
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (04): : 539 - 541
  • [7] Effective Control of Polymyalgia Rheumatica With Tocilizumab
    Al Rashidi, Abdulrahman
    Hegazi, Mohamed Osama
    Mohammad, Shaimaa A.
    Varghese, Alex
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (07) : 400 - 401
  • [8] Efficacy and Safety of Tocilizumab for Polymyalgia Rheumatica
    Lally, Lindsay
    Forbess, Lindsy J.
    Hatzis, Chris
    Spiera, Robert F.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab
    Kovacs, Attila
    Cserenyecz, Anita
    Baksay, Beata
    Kemeny, Eva
    Szekanecz, Zoltan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (07): : 389 - 391
  • [10] Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
    Farinango, Michelle
    Ansary, Akhil
    Dakka, Amulya
    Nazir, Zahra
    Shamim, Humaira
    Jean, Marie
    Umair, Muaaz
    Muddaloor, Pratyusha
    Chavarria, Yeny
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
12345